Paclitaxel for progressive basal cell carcinoma [4]

Journal of the American Academy of Dermatology

Volumn 54, Issue 2 SUPPL., 2006, Pages

  Barceló, Ramón ^a   Viteri, Ainhoa ^a   Muñoz, Alberto ^a   Gil Negrete, Aitziber ^a   Rubio, Itziar ^a   López Vivanco, Guillermo ^a  

^a HOSPITAL DE CRUCES   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; DOCETAXEL; PACLITAXEL;

BASAL CELL CARCINOMA; CLINICAL FEATURE; DEEP VEIN THROMBOSIS; DISEASE COURSE; FACE DEFORMITY; HUMAN; LETTER; LUNG DISEASE; LUNG EMBOLISM; METASTASIS; NEUROTOXICITY; PRIORITY JOURNAL; TREATMENT WITHDRAWAL;

EID: 30944457125     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaad.2005.07.036     Document Type: Article

References (6)

1. S.J. Miller Etiology and pathogenesis of basal cell carcinoma Clin Dermatol 13 1995 527 536
2. C.S.M. Wong, R.C. Strange, and J.T. Lear Clinical review: basal cell carcinoma BMJ 327 2003 794 798
3. Miller SJ, Andersen J, Beenken S, Berg D, Bowen G, Cheney RT, et al. Basal cell and squamous cell skin cancer, version 2.2005. Available from: http://www.nccn.org. Accessed March 8, 2005.
4. R.A. El Sobky, A.M. Kallab, P.M. Dainer, A.P. Jillella, and J.L. Lesher Successful treatment of an intractable case of hereditary basal cell carcinoma syndrome with paclitaxel Arch Dermatol 137 2001 827 828
5. M. Jefford, J.D. Kiffer, Somers, F.J. Daniel, and I.D. Davis Metastatic basal cell carcinoma: rapid symptomatic response to cisplatin and paclitaxel ANZ J Surg 74 2004 704 705
6. E.J. Buarque Chemotherapy with docetaxel and cisplatin for advanced and recurring basal cell carcinoma Ann Oncol 15 Suppl 3 2004 iii140